Home » Topics » Regulatory » Patents

Patents
RSS

Sanofi discloses cGMP PDE inhibitors for cardiovascular indications

April 21, 1998

New water-soluble dolastatin derivatives with potent antitumor activity

April 21, 1998

Heterocyclic tachykinin antagonists from Sanofi

April 21, 1998

MS&D discovers agents for safely enhancing cognition

April 21, 1998

Synthelabo discloses new benzimidazoles for urinary incontinence

April 21, 1998

Tricyclic compounds inhibiting protein farnesyltransferase claimed by Schering-Plough

April 21, 1998

Conjugates for imaging vascular thrombi developed at NeoRx/U. of Washington

April 20, 1998

P&U claims new distamycin derivatives and their use as antitumor and antiviral agents

April 20, 1998

Chiesi prepares new anticonvulsants and neuroprotective agents

April 20, 1998

COX-2 inhibitors claimed by AHP for arthritis, cancer and AD

April 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...